Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates

Emerg Infect Dis. 2022 Nov;28(11):2308-2311. doi: 10.3201/eid2811.220615.

Abstract

The plasmid pCD-METRO confers metronidazole resistance in Clostridioides difficile. We showed high sequence similarity among pCD-METRO plasmids from different isolates and identified pCD-METRO and associated metronidazole-resistant isolates in clinical and veterinary reservoirs in the Americas. We recommend using PCR or genomic assays to detect pCD-METRO in metronidazole-resistant C. difficile.

Keywords: Antimicrobial resistance; Brazil; Clostridioides difficile; South America; United States; bacteria; enteric infections; metronidazole; pCD-METRO; plasmid; sequence analysis; the Netherlands.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides
  • Clostridioides difficile* / genetics
  • Clostridium Infections* / drug therapy
  • Clostridium Infections* / veterinary
  • Drug Resistance, Bacterial / genetics
  • Humans
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests
  • Ribotyping

Substances

  • Metronidazole
  • Anti-Bacterial Agents